Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-11-17

Clinical Trial Update: A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind, placebo-controlled trial of L-carnitine and Piracetam for weakness and muscle fatigue in post-polio syndrome has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-carnitine (L-carnitine)
  • Piracetam (piracetam)

Snippet

Sponsor: Biolab Sanus Farmaceutica | Conditions: Postpoliomyelitis Syndrome | Phase 3 | Status: WITHDRAWN